AB
Alan Blake
Chief Executive Officer at Nuclein
· Austin, Texas, United States
Check size
Undisclosed
Lead stage
Private Equity-Funded
Deals tracked
3
Sectors
Molecular Diagnostics, Consumer Biotechnology
Molecular Diagnostics
Consumer Biotechnology
Private Equity-Funded Healthcare
Private Equity-Funded
Growth Stage
Austin, Texas
United States
About Alan
Alan Blake is an Executive Officer and Director with experience in institutional investment and corporate governance. Limited public data available on his specific firm affiliation, investment stage focus, and sector specialization
Investment thesis
Co-founder and CEO of a private equity-funded molecular diagnostics company focused on simple, impactful vision
Focus on impactful, simple vision in molecular diagnostics and consumer biotechnology, leveraging private equity funding for growth
Recent activity
Live platform data · proprietary, citable layer
Notable portfolio
Nuclein, LLC (Molecular Diagnostics)
Yorktown Technologies (GloFish®)
Frequently asked
Does Alan Blake invest at Private Equity-Funded stage?
Yes. They invest at Private Equity-Funded, Growth Stage stage.
Their geographic focus includes Austin, Texas, United States.
What is their typical check size?
Check size is not publicly disclosed. They currently invest through Nuclein.
What sectors does Alan Blake focus on?
Alan Blake primarily invests in Molecular Diagnostics, Consumer Biotechnology, Private Equity-Funded Healthcare.
Similar Molecular Diagnostics investors
Sign up for free to unlock similar investors
Are you a fit for Alan Blake?
See your match score free · under a minute